| Title: | FcyRIIb controls bone marrow plasma cell persistence and apoptosis. |
| Authors: | Xiang, Zou Cutler, Antony J Brownlie, Rebecca J Fairfax, Kirsten Lawlor, Kate E Severinson, Eva Walker, Elizabeth U Manz, Rudolf A Tarlinton, David M Smith, Kenneth G C |
| Issue Date: | 2007 |
| Publisher: | Nature Immunology |
| Citation: | Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E, Walker EU, Manz RA, Tarlinton DM and Smith KGC. “FcγRIIb controls bone marrow plasma cell persistence and apoptosis.” Nature Immunology 2007; 8:419 - 429. |
| Abstract: | The survival of long-lived plasma cells, which produce most serum immunoglobulin, is central to humoral immunity. We found here that the inhibitory Fc receptor FcgammaRIIb was expressed on plasma cells and controlled their persistence in the bone marrow. Crosslinking FcgammaRIIb induced apoptosis of plasma cells, which we propose contributes to the control of their homeostasis and suggests a method for therapeutic deletion. Plasma cells from mice prone to systemic lupus erythematosus did not express FcgammaRIIb and were protected from apoptosis. Human plasmablasts expressed FcgammaRIIb and were killed by crosslinking, as were FcgammaRIIb-expressing myeloma cells. Our results suggest that FcgammaRIIb controls bone marrow plasma cell persistence and that defects in it may contribute to autoantibody production. |
| URI: | http://www.dspace.cam.ac.uk/handle/1810/243988 |
| Appears in Collections: | Scholarly works - Medicine |
Files in This Item:
|
| Additional resources for this item |
|---|
| search for alternative versions in eresources@cambridge |
| retrieve citation metadata in EndNote format |
This item is licensed under a Creative Commons License
This item has been accessed 261 times.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

